| Item Type | Name |
|
Concept
|
Depressive Disorder, Major
|
|
Academic Article
|
Preventing recurrent depression: long-term treatment for major depressive disorder.
|
|
Academic Article
|
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
|
|
Academic Article
|
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
|
|
Academic Article
|
SNRIs in the management of acute major depressive disorder.
|
|
Academic Article
|
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
|
|
Academic Article
|
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
|
|
Academic Article
|
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
|
|
Academic Article
|
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
|
|
Academic Article
|
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
|
|
Academic Article
|
Augmentation strategies to increase antidepressant tolerability.
|
|
Academic Article
|
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.
|
|
Academic Article
|
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
|
|
Academic Article
|
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Evidence for the use of l-methylfolate combined with antidepressants in MDD.
|
|
Academic Article
|
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
|
|
Academic Article
|
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
|
|
Academic Article
|
Residual symptoms in major depressive disorder: prevalence, effects, and management.
|
|
Academic Article
|
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
|
|
Academic Article
|
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
|
|
Academic Article
|
The pro-inflammatory profile of depressed patients is (partly) related to obesity.
|
|
Academic Article
|
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
|
|
Academic Article
|
Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study.
|
|
Academic Article
|
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164.
|
|
Academic Article
|
Mood disturbance versus other symptoms of depression in multiple sclerosis.
|
|
Academic Article
|
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
|
|
Academic Article
|
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
|
|
Academic Article
|
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder.
|
|
Academic Article
|
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
|
|
Academic Article
|
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
|
|
Academic Article
|
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
|
|
Academic Article
|
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
|
|
Academic Article
|
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
|
|
Academic Article
|
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
|
|
Academic Article
|
Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat Depression.
|